Onyx reports encouraging phase II results of ONYX-015 in head and neck cancer Nov. 27, 1998 No Comments
Onyx presents new addition to anticancer arsenal at gene therapy conference Nov. 26, 1998 No Comments
Ligand initiates phase II trial with Targretin capsules for treatment of breast cancer Nov. 26, 1998 No Comments
New combretastatin A-4 derivative and prodrug profiled at ongoing scientific meeting Nov. 25, 1998 No Comments
Efficacy trial of new prostate cancer treatment initiated at eight leading research centers Nov. 25, 1998 No Comments
Tanabe presents water-soluble taxane with better activity than paclitaxel and docetaxel Nov. 25, 1998 No Comments